Cantor Fitzgerald analyst Sarah James lowered the firm’s price target on Acadia Healthcare (ACHC) to $22 from $25 and keeps a Neutral rating on the shares. Cantor remains on the sidelines as volumes and rate headwinds continue to pressure the recovery timeline with no clear catalyst for reversal, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare price target lowered to $28 from $31 at UBS
- Acadia Healthcare Reports Q3 Revenue Growth Amid Challenges
- Acadia Healthcare sentiment likely to worsen further, says Cantor Fitzgerald
- Acadia Healthcare COO Nasser Khan resigns
- Acadia Healthcare lowers FY25 adjusted EPS $2.35-$2.45 from $2.45-$2.65